Rocket Pharmaceuticals Stock Today
| RCKT Stock | USD 22.80 0.68 2.90% |
Performance0 of 100
| Odds Of DistressLess than 24
|
Rocket Pharmaceuticals is selling for under 22.80 as of the 20th of April 2024; that is -2.9 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 22.32. Rocket Pharmaceuticals has about a 24 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Rocket Pharmaceuticals are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 21st of January 2024 and ending today, the 20th of April 2024. Click here to learn more.
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. Rocket Pharmaceuticals, Inc. is headquartered in Cranbury, New Jersey. The company has 90.5 M outstanding shares of which 10.52 M shares are at this time shorted by private and institutional investors with about 13.69 trading days to cover. More on Rocket Pharmaceuticals
Moving together with Rocket Stock
| 0.64 | JNJ | Johnson Johnson Financial Report 18th of July 2024 | PairCorr |
Moving against Rocket Stock
| 0.6 | NUVB | Nuvation Bio Financial Report 2nd of May 2024 | PairCorr |
Follow Valuation Odds of Bankruptcy
Financial Report 2nd of May 2024
Rocket Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Rocket Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Rocket Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President CEO, Director | Gaurav Shah |
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
| Financial Strength Based on the key indicators related to Rocket Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Rocket Pharmaceuticals is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of Rocket Pharmaceuticals is based on its profitability, leverage, liquidity, source of funds, and operating efficiency. | |
Rocket Pharmaceuticals (RCKT) is traded on NASDAQ Exchange in USA. It is located in 9 Cedarbrook Drive, Cranbury, NJ, United States, 08512 and employs 268 people. Rocket Pharmaceuticals is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.13 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Rocket Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Rocket Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Rocket Pharmaceuticals conducts business under Biotechnology sector and is part of Health Care industry. The entity has 90.5 M outstanding shares of which 10.52 M shares are at this time shorted by private and institutional investors with about 13.69 trading days to cover.
Rocket Pharmaceuticals currently holds about 321.37 M in cash with (194.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.87.
Check Rocket Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationRocket Pharmaceuticals has a total of 90.5 Million outstanding shares. The majority of Rocket Pharmaceuticals outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Rocket Pharmaceuticals to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Rocket Pharmaceuticals. Please pay attention to any change in the institutional holdings of Rocket Pharmaceuticals as this could imply that something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Rocket Ownership Details
Rocket Pharmaceuticals Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Rocket Pharmaceuticals market risk premium is the additional return an investor will receive from holding Rocket Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Rocket Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Rocket Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Rocket Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.
| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.30) | |||
| Total Risk Alpha | (0.61) | |||
| Treynor Ratio | 4.01 |
Rocket Stock Against Markets
Picking the right benchmark for Rocket Pharmaceuticals stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Rocket Pharmaceuticals stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Rocket Pharmaceuticals is critical whether you are bullish or bearish towards Rocket Pharmaceuticals at a given time. Please also check how Rocket Pharmaceuticals' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Rocket Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Forecasting Now
Equity ForecastingUse basic forecasting models to generate price predictions and determine price momentum |
| All Next | Launch Module |
Rocket Pharmaceuticals Corporate Directors
Rocket Pharmaceuticals corporate directors refer to members of a Rocket Pharmaceuticals board of directors. The board of directors generally takes responsibility for the Rocket Pharmaceuticals' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Rocket Pharmaceuticals' board members must vote for the resolution. The Rocket Pharmaceuticals board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Gary Phillips | Independent Director | Profile | |
| Patrick Machado | Independent Director | Profile | |
| Timothy Barberich | Independent Director | Profile | |
| Paul Howes | Independent Director | Profile |
How to buy Rocket Stock?
Before investing in Rocket Pharmaceuticals, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Rocket Pharmaceuticals. To buy Rocket Pharmaceuticals stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Rocket Pharmaceuticals. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Rocket Pharmaceuticals stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Rocket Pharmaceuticals stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Rocket Pharmaceuticals stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Rocket Pharmaceuticals, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Rocket Stock please use our How to Invest in Rocket Pharmaceuticals guide.
Already Invested in Rocket Pharmaceuticals?
The danger of trading Rocket Pharmaceuticals is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Rocket Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Rocket Pharmaceuticals. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Rocket Pharmaceuticals is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Rocket Pharmaceuticals is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Rocket Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Rocket Pharmaceuticals Stock. Highlighted below are key reports to facilitate an investment decision about Rocket Pharmaceuticals Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rocket Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry. For more information on how to buy Rocket Stock please use our How to Invest in Rocket Pharmaceuticals guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Complementary Tools for Rocket Stock analysis
When running Rocket Pharmaceuticals' price analysis, check to measure Rocket Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rocket Pharmaceuticals is operating at the current time. Most of Rocket Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Rocket Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rocket Pharmaceuticals' price. Additionally, you may evaluate how the addition of Rocket Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
Is Rocket Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rocket Pharmaceuticals. If investors know Rocket will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rocket Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Rocket Pharmaceuticals is measured differently than its book value, which is the value of Rocket that is recorded on the company's balance sheet. Investors also form their own opinion of Rocket Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Rocket Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rocket Pharmaceuticals' market value can be influenced by many factors that don't directly affect Rocket Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rocket Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Rocket Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rocket Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.